Announced Fri, 29 May · 14:34 IST

Audited Financial results for the year ended on March 31, 2026 along with auditors report is attached

Pat Growth 25pctEbitda Margin ExpansionExceptional ItemResults View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+2.0%1-day move
₹760.00
prior close
₹759.80
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0+0.0+0.0+0.3+2.0+1.2+5.9+0.9+2.6+12.4
Up moveDown movePending
AI summary

Mercury Laboratories Ltd reported audited full-year results for FY2025-26 (ending March 31, 2026). Revenue from operations grew 8.6% to ₹5,687.63 lakh from ₹5,236.92 lakh. Profit before tax rose 42.3% to ₹663.72 lakh, and profit after tax grew 39.8% to ₹482.85 lakh. EPS stands at ₹40.24 per share (face value ₹10). The Board recommended a final dividend of 35% (₹3.50 per share), subject to shareholder approval at the 45th AGM on September 28, 2026. An exceptional item was recorded in Q4 due to additional provisions for gratuity and leave liabilities arising from new labour codes effective November 2025. Statutory auditor Naresh & Co. issued an unmodified (clean) opinion. Cash flow from operations was ₹423.96 lakh, with cash and bank balances rising sharply to ₹589.95 lakh from ₹219.32 lakh a year ago.

Likely market impact

Strong bottom-line growth with PAT up ~40% and EBITDA margin expansion of ~3.3 percentage points signals operational efficiency gains. The clean audit and healthy cash position are positives. The exceptional item (labour code adjustment) is one-time in nature and does not affect underlying earnings quality.